4-1BB immunotherapy: advances and hurdles
Abstract Since its initial description 35 years ago as an inducible molecule expressed in cytotoxic and helper T cells, 4-1BB has emerged as a crucial receptor in T-cell-mediated immune functions. Numerous studies have demonstrated the involvement of 4-1BB in infection and tumor immunity. However, t...
Main Authors: | Rohit Singh, Young-Ho Kim, Sang-Jin Lee, Hyeon-Seok Eom, Beom K. Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-01-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-023-01136-4 |
Similar Items
-
4-1BB: A promising target for cancer immunotherapy
by: Alyssa Min Jung Kim, et al.
Published: (2022-09-01) -
Accelerating Cancer Immunotherapy Through 4-1BB Activation
by: Todd eBartkowiak, et al.
Published: (2015-06-01) -
Targeting 4-1BB for tumor immunotherapy from bench to bedside
by: Ya-Tao Wang, et al.
Published: (2022-09-01) -
Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
by: Almudena Torres-Cornejo, et al.
Published: (2017-04-01) -
The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles
by: Jun-O. Jin, et al.
Published: (2021-05-01)